who are not suitable for surgical or transcatheter edge-to-edge repair treatments. 4C Medical Technologies CEO and president ...
The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback